Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma

Mantle cell lymphoma is a relatively rare type of mature B-cell non-Hodgkin's lymphoma with an incidence of approximately 8 cases per million persons per year. In patients with mantle cell lymphoma, there are rare case reports of the potentially life-threatening consequences of splenic rupture...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Jared, Chiruka, Shingi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476069/
https://www.ncbi.nlm.nih.gov/pubmed/31089434
http://dx.doi.org/10.1155/2019/2429098
Descripción
Sumario:Mantle cell lymphoma is a relatively rare type of mature B-cell non-Hodgkin's lymphoma with an incidence of approximately 8 cases per million persons per year. In patients with mantle cell lymphoma, there are rare case reports of the potentially life-threatening consequences of splenic rupture and rituximab-induced acute thrombocytopenia (RIAT) occurring separately, but there are no reports of these occurring in the same patient. Whilst rare, they are important to be aware of as early detection may prevent fatal outcomes.

Ejemplares similares